Skip to content
  • HOME
  • MYOSTRAIN
  • MYOSTRESS
  • CLINICAL APPLICATIONS
    • CARDIO ONCOLOGY
    • Preventive Cardiology: Early Detection
    • Heart Failure Management
    • Stress Testing
  • COMPANY
    • Management Team
    • Board of Directors
  • News
  • Publications
  • GET MYOHEALTH
  • HOME
  • MYOSTRAIN
  • MYOSTRESS
  • CLINICAL APPLICATIONS
    • CARDIO ONCOLOGY
    • Preventive Cardiology: Early Detection
    • Heart Failure Management
    • Stress Testing
  • COMPANY
    • Management Team
    • Board of Directors
  • News
  • Publications
  • GET MYOHEALTH

Author: My0c4rd14L

Vithas signs the first Corporate License Agreement in Spain with Myocardial Solutions to implement MyoStrain® and MyoStress®

HM Hospitals partners with Myocardial Solutions to assess the cardiotoxicity of chemotherapy and the cardiac function of cancer patients

MyoStrain and MyoStress launch at Buff Medical Resort to improve cardiac care in Germany

The Ramón y Cajal Hospital incorporates innovative technology to prevent heart disease

← Previous
Linkedin-in Facebook-f Instagram X-twitter
  • MYOSTRAIN
  • MYOSTRESS
  • CARDIO ONCOLOGY
  • Early Detection
  • Heart Failure Management
  • Stress Testing
  • Contact
  • MYOSTRAIN
  • MYOSTRESS
  • CARDIO ONCOLOGY
  • Early Detection
  • Heart Failure Management
  • Stress Testing
  • Contact
  • Terms of Service
  • Privacy policy
  • Cookie Policy

© 2025 Myocardial Solutions Inc. All rights reserved.